Krystal Biotech, Inc. (KRYS:NASDAQ) closed at $317.38 on October 16, 2026, down 3.82% on the day. The stock trades 17.0% below its 52-week high of $382.54 and 73.4% above its 52-week low of $183.03. Over the past year, it gained 75.2%. Krystal Biotech, Inc. is part of the Health Care sector (Biotechnology: Biological Products (No Diagnostic Substances)).
| 5D | 1M | 3M | 6M | 1Y |
|---|---|---|---|---|
| -0.62% | -1.98% | -2.72% | +19.35% | +75.22% |
In 252 trading sessions since October 15, 2025, KRYS closed higher on 133 days (53%). Its best day was May 4, 2026 (+7.86%) and its worst was August 3, 2026 (-8.37%). It never moved 10% or more in a single session.
Krystal Biotech Inc is a biopharmaceutical company. It uses gene therapy treatments for patients suffering from rare debilitating disorders.
Find more stocks like KRYS with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.